Premium
Prenatal exclusion of ornithine transcarbamylase (OTC) by using RFLP analysis
Author(s) -
Liechti S.,
Dionisi Vici C.,
Bachmann C.,
Mazziotta M. R. M.,
Bartuli A.,
Sabetta G.
Publication year - 1990
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/bf01800215
Subject(s) - ornithine transcarbamylase deficiency , restriction fragment length polymorphism , ornithine transcarbamylase , ornithine carbamoyltransferase , genetics , heterozygote advantage , prenatal diagnosis , metabolic disease , genotype , medicine , biology , pregnancy , ornithine , urea cycle , fetus , amino acid , arginine , gene
Summary The use of restriction fragment length polymorphism studies for prenatal exclusion of OTC deficiency in a carrier mother is reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom